The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The global intravenous immunoglobulin (IVIg) market is charting a course of substantial growth, with an anticipated increase from $12.86 billion in 2022 to $13.75 billion in 2023, showcasing a commendable compound annual growth rate (CAGR) of 7.0%. Peering into the future, the market is poised to reach $17.95 billion in 2027, driven by a CAGR of 6.9%. Let’s delve into the key factors steering the trajectory of this vital healthcare sector.

Increasing Geriatric Population: A Driving Force

1. Understanding the Geriatric Population

• The geriatric population comprises individuals aged 65 and above.
• Aging leads to compromised immunity and a decline in antibody production, necessitating the use of immunoglobulins.

2. Global Geriatric Landscape

• In 2021, India had 138 million elderly individuals, expected to rise to 194 million by 2031.
• WHO predicts that by 2030, 1 in 6 people worldwide will be 60 years or older, reaching 1.4 billion compared to 1 billion in 2020.

3. Implications on IVIg Market

• The aging demographic fuels the demand for immunoglobulins, driving the growth of the intravenous immunoglobulin market.
• Increasing geriatric populations globally contribute significantly to the market expansion.

Major Players Steering the Course

1. Industry Pioneers

• Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings Inc., CSL Behring, Grifols SA, Kedrion SpA, Shanghai RAAS Blood Products Co Ltd., Octapharma AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., Bayer AG, LFB Biotechnologies SAS, BDI Pharma Inc., Hualan Biological Engineering Inc., ADMA Biologics Inc., Bharat Serums and Vaccines Limited, Sanquin Plasma Products BV, Prothya Biosolutions BV, Sichuan Yuanda Shuyang Pharmaceutical Co Ltd., and Pfizer Inc. are major players shaping the intravenous immunoglobulin market.

2. Industry Dynamics

• Intense competition propels major players to focus on innovation, research, and development to maintain their market positions.

Innovating for Impact: Product Innovation Trend

1. Key Trend: Product Innovation

• Product innovation is a prominent trend gaining traction in the intravenous immunoglobulin market.
• Companies prioritize the development of new products to address rare diseases and sustain their market presence.

2. Exemplary Innovation: Octagam 10%

• In June 2021, Octapharma introduced ‘Octagam 10%’, a human plasma-derived IVIg, gaining EU approval for immunotherapy in adults with dermatomyositis.
• The innovative product is a breakthrough for dermatomyositis, a rare autoimmune disorder.

3. Market Impact

• Product innovation enhances treatment options, addressing unmet medical needs and contributing to the market’s overall growth.

Comprehensive Market Segmentation

1. Type-Based Segmentation

• IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A), IgE (Immunoglobulin E), IgD (Immunoglobulin D)

2. Distribution Channel

• Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

3. Application-Based Segmentation

• Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Primary Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Other Applications

4. End-User Segmentation

• Hospitals, Clinics, Home Care

Regional Dynamics: North America Leads, Asia-Pacific Surges

1. North America’s Prominence

• North America secured the largest market share in the intravenous immunoglobulin market in 2022.
• The region’s advanced healthcare infrastructure contributes to its leadership position.

2. Asia-Pacific’s Growth Trajectory

• Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, signifying a shift in global healthcare dynamics.

View More On The Intravenous Immunoglobulin Market Report 2023 – https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Request A Sample Of The Global Intravenous Immunoglobulin Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8538&type=smp

The Intravenous Immunoglobulin Global Market Report 2023  provides a comprehensive overview on the intravenous immunoglobulin market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Immunoglobulins Global Market Report 2023
Immunofluorescence Assay Global Market Report 2023
Immunosuppressants Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model